Previous close | 13.30 |
Open | 13.40 |
Bid | 15.50 |
Ask | 17.10 |
Strike | 490.00 |
Expiry date | 2025-01-17 |
Day's range | 13.10 - 13.40 |
Contract range | N/A |
Volume | |
Open interest | 81 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...